{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:15:45Z","timestamp":1774120545848,"version":"3.50.1"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4,1]]},"DOI":"10.1164\/rccm.201302-0230ed","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T18:04:52Z","timestamp":1365098692000},"page":"668-671","source":"Crossref","is-referenced-by-count":34,"title":["Chronic Obstructive Pulmonary Disease is Just One Component of the Complex Multimorbidities in Patients with COPD"],"prefix":"10.1093","volume":"187","author":[{"given":"Enrico M.","family":"Clini","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Modena & Reggio Emilia, Modena, Italy and Rehabilitation Unit, Villa Pineta Hospital, Pavullo n\/F, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Begh\u00e9","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Modena & Reggio Emilia, Modena, Italy and Pneumology Unit, AOU Policlinico di Modena, Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo M.","family":"Fabbri","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Modena & Reggio Emilia, Modena, Italy and Pneumology Unit, AOU Policlinico di Modena, Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,4,1]]},"reference":[{"key":"2026032100534994600_bib1","article-title":"Multimorbidity in older adults","author":"Salive","journal-title":"Epidemiol Rev"},{"key":"2026032100534994600_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","article-title":"Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study","volume":"380","author":"Barnett","year":"2012","journal-title":"Lancet"},{"key":"2026032100534994600_bib3","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.arr.2011.03.003","article-title":"Aging with multimorbidity: a systematic review of the literature","volume":"10","author":"Marengoni","year":"2011","journal-title":"Ageing Res Rev"},{"key":"2026032100534994600_bib4","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ejheart.2006.01.010","article-title":"Heart failure and chronic obstructive pulmonary disease: an ignored combination?","volume":"8","author":"Rutten","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"2026032100534994600_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1164\/rccm.201210-1953ED","article-title":"Chronic obstructive pulmonary disease and cardiovascular diseases: a \u201cvulnerable\u201d relationship","volume":"187","author":"Sin","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100534994600_bib6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1586\/ers.11.62","article-title":"Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art","volume":"5","author":"Patel","year":"2011","journal-title":"Expert Rev Respir Med"},{"key":"2026032100534994600_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1164\/rccm.201201-0034OC","article-title":"Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease","volume":"186","author":"Divo","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100534994600_bib8","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1164\/rccm.201209-1665OC","article-title":"Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease","volume":"187","author":"Vanfleteren","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100534994600_bib9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1164\/rccm.201208-1565OC","article-title":"Effects of cardiovascular drugs on mortality in severe chronic obstructive pulmonary disease: a time-dependent analysis","volume":"187","author":"Ekstr\u00f6m","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100534994600_bib10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","article-title":"Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD Executive Summary","volume":"187","author":"Vestbo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100534994600_bib11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"14","author":"ESC Committee for Practice Guidelines","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026032100534994600_bib12","doi-asserted-by":"crossref","first-page":"e637S","DOI":"10.1378\/chest.11-2306","article-title":"Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis, 9th ed.: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Vandvik","year":"2012","journal-title":"Chest"},{"key":"2026032100534994600_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jch.12049","article-title":"Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of the obesity society and the American Society of Hypertension","volume":"15","author":"Landsberg","year":"2013","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2026032100534994600_bib14","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1513\/pats.200809-101TH","article-title":"Treatment of chronic obstructive pulmonary disease and its comorbidities","volume":"5","author":"Luppi","year":"2008","journal-title":"Proc Am Thorac Soc"},{"key":"2026032100534994600_bib15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1513\/pats.201208-063ST","article-title":"How to integrate multiple comorbidities in guideline development: article 10 in integrating and coordinating efforts in COPD guideline development. An official ATS\/ERS workshop report","volume":"9","author":"Fabbri","year":"2012","journal-title":"Proc Am Thorac Soc"},{"key":"2026032100534994600_bib16","doi-asserted-by":"crossref","first-page":"e35806","DOI":"10.1371\/journal.pone.0035806","article-title":"Comorbidity and sex-related differences in mortality in oxygen-dependent chronic obstructive pulmonary disease","volume":"7","author":"Ekstr\u00f6m","year":"2012","journal-title":"PLoS ONE"},{"key":"2026032100534994600_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1191\/1479972304cd011oa","article-title":"BMI and oral glucocorticoids as predictors of prognosis in COPD patients on long-term oxygen therapy","volume":"1","author":"Ringbaek","year":"2004","journal-title":"Chron Respir Dis"},{"key":"2026032100534994600_bib18","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/thx.2010.157529","article-title":"Increased platelet activation in patients with stable and acute exacerbation of COPD","volume":"66","author":"Maclay","year":"2011","journal-title":"Thorax"},{"key":"2026032100534994600_bib19","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2174\/157016110791330780","article-title":"Why are people with \u201cpoor lung function\u201d at increased atherothrombotic risk? A critical review with potential therapeutic indications","volume":"8","author":"Fimognari","year":"2010","journal-title":"Curr Vasc Pharmacol"},{"key":"2026032100534994600_bib20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.08-2918","article-title":"A postmortem analysis of major causes of early death in patients hospitalized with COPD exacerbation","volume":"136","author":"Zvezdin","year":"2009","journal-title":"Chest"},{"key":"2026032100534994600_bib21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1164\/rccm.201206-1046OC","article-title":"Chronic obstructive pulmonary disease and lipid core carotid artery plaques in the elderly: the Rotterdam study","volume":"187","author":"Lahousse","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100534994600_bib22","doi-asserted-by":"crossref","first-page":"e89S","DOI":"10.1378\/chest.11-2293","article-title":"Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis, 9th ed.: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Eikelboom","year":"2012","journal-title":"Chest"},{"key":"2026032100534994600_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0262-1746(87)90096-5","article-title":"Stimulation of aggregation and thromboxane A2 formation of human platelets by hypoxia","volume":"29","author":"Ponicke","year":"1987","journal-title":"Prostaglandins Leukot Med"},{"key":"2026032100534994600_bib24","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1056\/NEJMoa041747","article-title":"Risk of myocardial infarction and stroke after acute infection or vaccination","volume":"351","author":"Smeeth","year":"2004","journal-title":"N Engl J Med"},{"key":"2026032100534994600_bib25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1111096","article-title":"Rivaroxaban for thromboprophylaxis in acutely ill medical patients","volume":"368","author":"Cohen","year":"2013","journal-title":"N Engl J Med"},{"key":"2026032100534994600_bib26","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1586\/ers.12.69","article-title":"Long-term oxygen therapy","volume":"6","author":"Jindal","year":"2012","journal-title":"Expert Rev Respir Med"},{"key":"2026032100534994600_bib27","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1172\/JCI27196","article-title":"Platelets in inflammation and atherogenesis","volume":"115","author":"Gawaz","year":"2005","journal-title":"J Clin Invest"},{"key":"2026032100534994600_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1164\/rccm.201203-0455PP","article-title":"The relationship between lung inflammation and cardiovascular disease","volume":"186","author":"Van Eeden","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100534994600_bib29","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1164\/rccm.200806-963ED","article-title":"Beta-blockers are safe in patients with chronic obstructive pulmonary disease, but only with caution","volume":"178","author":"Cazzola","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100534994600_bib30","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jacc.2011.02.020","article-title":"Heart failure and chronic obstructive pulmonary disease the quandary of beta-blockers and beta agonists","volume":"57","author":"Hawkins","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026032100534994600_bib31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1751-7176.2011.00553.x","article-title":"\u03b2-blockade: benefits beyond blood pressure reduction?","volume":"14","author":"Cockcroft","year":"2012","journal-title":"J Clin Hypertens"},{"key":"2026032100534994600_bib32","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1164\/rccm.201101-0123ED","article-title":"Dying from, and with, chronic obstructive pulmonary disease","volume":"183","author":"Rosenberg","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100534994600_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(12)60482-6","article-title":"Multimorbidity: redesigning health care for people who use it","volume":"380","author":"Salisbury","year":"2012","journal-title":"Lancet"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/187\/7\/668\/67266982\/ajrccm_187_7_668.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/187\/7\/668\/67266982\/ajrccm_187_7_668.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T04:54:18Z","timestamp":1774068858000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/187\/7\/668\/8510088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,1]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,4,1]]},"published-print":{"date-parts":[[2013,4,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201302-0230ed","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,4]]},"published":{"date-parts":[[2013,4,1]]}}}